# Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula

> **NCT01314092** · PHASE2 · TERMINATED · sponsor: **Anterogen Co., Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Complex Perianal Fistula

## Interventions

- **BIOLOGICAL:** Autologous cultured adipose derived stem cells(low dose group)
- **BIOLOGICAL:** Autologous cultured adipose derived stem cells(high dose group)

## Key facts

- **NCT ID:** NCT01314092
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Difficulty recruiting subjects.
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314092, "Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01314092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*